Table 5.
Metric | SEER/CMS Earle et al. |
MGH Temel et. al. |
Case Western Von Gruenigen et. al. |
University of Alabama Fauci et. al. |
Montefiore Medical Center |
---|---|---|---|---|---|
Disease site | Breast, colorectal, lung gastrointestinal | Metastatic lung cancer | Ovarian cancer | Gynecologic malignancies | Gynecologic malignancies |
Chemo 6–8 months of death | 82% | 64% | 75% | ||
Chemo 2–6 weeks of death | 14% | 24% | 29% | ||
Duration of hospice | 11 days 4 days |
24 days (1–180) | 22 days | 16 days (1–149) | |
Hospice Utilization | 28% | 21% | 45% | ||
DNR/DNI | 26% | 64% |